EVC2 anticorps (AA 1246-1308)
Aperçu rapide pour EVC2 anticorps (AA 1246-1308) (ABIN1885993)
Antigène
Voir toutes EVC2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1246-1308
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 1246 and 1308 of EVC2
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- EVC2 (Ellis Van Creveld Syndrome 2 (EVC2))
-
Autre désignation
- EVC2
-
Poids moléculaire
- 148 kDa
-
ID gène
- 132884
-
NCBI Accession
- NM_147127, NP_667338
-
Pathways
- Signalisation Hedgehog
Antigène
-